Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.

Autor:	Mauri G; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; IFOM, Istituto Fondazione di Oncologia Molecolare ETS, Milan, Italy.; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Patelli G; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Gori V; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Lauricella C; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Mussolin B; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy., Amatu A; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bencardino K; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Tosi F; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bonazzina E; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bonoldi E; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bardelli A; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.; Department of Oncology, Università degli Studi di Torino, Turin, Italy., Siena S; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Sartore-Bianchi A; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Jazyk:	angličtina
Zdroj:	Frontiers in oncology [Front Oncol] 2023 Mar 28; Vol. 13, pp. 1147497. Date of Electronic Publication: 2023 Mar 28 (Print Publication: 2023).
DOI:	10.3389/fonc.2023.1147497
Abstrakt:	[This corrects the article DOI: 10.3389/fonc.2022.1030232.]. (Copyright © 2023 Mauri, Patelli, Gori, Lauricella, Mussolin, Amatu, Bencardino, Tosi, Bonazzina, Bonoldi, Bardelli, Siena and Sartore-Bianchi.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu